Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening
Open Access
- 29 June 2012
- Vol. 67 (10), 874-881
- https://doi.org/10.1136/thoraxjnl-2012-201747
Abstract
Background Long-term benefits of newborn screening (NBS) for cystic fibrosis (CF) have been established with respect to nutritional status, but effects on pulmonary health remain unclear. Hypothesis With early diagnosis and commencement of standardised treatment, lung function at ∼3 months of age is normal in NBS infants with CF. Methods Lung clearance index (LCI) and functional residual capacity (FRC) using multiple breath washout (MBW), plethysmographic (pleth) FRC and forced expirations from raised lung volumes were measured in 71 infants with CF (participants in the London CF Collaboration) and 54 contemporaneous healthy controls age ∼3 months. Results Compared with controls, and after adjustment for body size and age, LCI, FRCMBW and FRCpleth were significantly higher in infants with CF (mean difference (95% CI): 0.5 (0.1 to 0.9), p=0.02; 0.4 (0.1 to 0.7), p=0.02 and 0.9 (0.4 to 1.3), p0.5) and flows (FEF25–75) were significantly lower (−0.9 (−1.3 to −0.6), p1.96 z-scores) and 25% (17/68) an abnormally low FEV0.5 (below −1.96 z-scores). While only eight infants with CF had abnormalities of LCI and FEV0.5, using both techniques identified abnormalities in 35% (24/68). Hyperinflation (FRCpleth >1.96 z-scores) was identified in 18% (10/56) of infants with CF and was significantly correlated with diminished FEF25–75 (r=−0.43, p0.5. Conclusion Despite early diagnosis of CF by NBS and protocol-driven treatment in specialist centres, abnormal lung function, with increased ventilation inhomogeneity and hyperinflation and diminished airway function, is evident in many infants with CF diagnosed through NBS by 3 months of age.Keywords
This publication has 42 references indexed in Scilit:
- Designing the new UK-WHO growth charts to enhance assessment of growth around birthArchives of Disease in Childhood: Fetal & Neonatal, 2012
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Multicenter Evaluation of Infant Lung Function Tests as Cystic Fibrosis Clinical Trial EndpointsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic FibrosisThe Journal of Pediatrics, 2009
- Newborn screening for cystic fibrosis: evidence for benefitArchives of Disease in Childhood, 2008
- Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume testsThorax, 2007
- Evidence on Improved Outcomes with Early Diagnosis of Cystic Fibrosis Through Neonatal Screening: Enough is Enough!The Journal of Pediatrics, 2005
- Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in EuropeThe Journal of Pediatrics, 2005
- Exploring the relationship between forced maximal flow at functional residual capacity and parameters of forced expiration from raised lung volume in healthy infantsPediatric Pulmonology, 2002
- Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screeningThe Journal of Pediatrics, 1989